Andrew Filby

Professor Andrew Filby is a prominent faculty member at Newcastle University specializing in advanced cytometry techniques and immunological research. His work bridges cutting-edge methodological developments with critical clinical applications across multiple disease areas including transplantation immunology, cancer research, and infectious disease responses.

Professor Filby's research centers on imaging flow cytometry and its applications in characterizing immune cell populations. He has pioneered approaches for label-free cell identification using machine learning algorithms, significantly advancing capabilities in white blood cell classification and cancer cell analysis. His work spans both methodological innovation and clinical translation, with particular emphasis on understanding immune responses in COVID-19 pathology, rheumatoid arthritis, and lung transplantation complications. The integration of computational approaches with traditional cytometry represents a hallmark of his research program.

Analysis of Professor Filby's extensive publication record reveals a clear evolution from foundational cytometry methodology development toward increasingly sophisticated applications in disease mechanisms. His recent work demonstrates strong collaborative efforts with clinical researchers, particularly in transplantation immunology with Professor Andrew Fisher and in cellular analysis with Dr. David McDonald. The consistent focus on developing quantitative approaches for cell cycle analysis, immune cell characterization, and tumor microenvironment assessment underscores his commitment to advancing precision in immunological research.

Professor Filby has made significant contributions to the field through his co-authorship of the second edition of the Guidelines for the use of flow cytometry and cell sorting in immunological studies, which serves as a key reference for researchers worldwide. His work on biosafety protocols during the pandemic also demonstrates leadership in maintaining research continuity during global health crises.

His laboratory appears to function as a critical resource for cellular analysis at Newcastle University, supporting numerous research groups through advanced cytometry services and expertise. The frequent authorship on methodological papers suggests strong mentoring of junior researchers in cytometry techniques and data analysis approaches.